Developer docs
API playgroundTry for free, no card

Search company profiles

ECCO

Full company profile

uuid0008136

Namestring
ECCO
Legal namestring
European Cancer Organisation
Company typeenum
Private
Founded yearint
1981
Descriptiontext

The European Cancer Organisation (ECO, formerly ECCO and originally the Federation of European Cancer Societies) is a Brussels-based not-for-profit federation founded in 1981 and rebranded under its current name in 2007. It convenes 41 member societies and patient advocacy groups spanning oncology, nursing, surgical oncology, radiotherapy, paediatric oncology, and cancer research to build consensus and influence European cancer policy, most notably contributing to Europe's Beating Cancer Plan with 12 recommendations during the 2020 consultation. ECO operates nine Focused Topic Networks (Prevention/HPV/Quality of Life/Digital Health/Inequalities/Workforce/Research/Emergencies) and convenes the European Parliamentarians for Cancer Action group of more than 130 policymakers.

ECO's product surface is policy- and community-oriented rather than commercial. Offerings include the annual European Cancer Summit, Community 365 year-round roundtables, policy publications (ECO Good Practice Guide on HPV Vaccination, Closing the Gaps cervical cancer screening report, Essential Requirements for Quality Cancer Care series), data visualisation tools (European Cancer Pulse, European Cancer Screening Policy Index), and policy frameworks (European Code of Cancer Practice). It also delivers EU-funded projects including INTERACT-EUROPE 100 and EUonQoL.

ECO's business model is a subscription-style federation: recurring membership contributions from 41 member societies, event participation revenue, and project funding from EU programmes (including the EU Mission on Cancer). It does not sell commercial products or services. Pricing is not publicly disclosed. The customer base is fragmented across oncology professionals, patient advocates, EU institutions, and national policymakers, with EU institutional engagement concentrated in Brussels via its Rue de la Science 41 headquarters.

Short descriptiontext

The European Cancer Organisation is a Brussels-based not-for-profit federation of 41 oncology member societies and patient advocacy groups that convenes stakeholders, builds policy consensus, and influences EU cancer policy through the European Cancer Summit, Focused Topic Networks, and policy publications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBrussels, Belgium
HQ citystring
Brussels
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer policy advocacy, oncology federation, health policy convening, cancer care consensus, multidisciplinary oncology
Industry3 codes
1Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships
CodeHLAJAOALPrimaryYes
2Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
CodeBPADANAJPrimaryNo
3Association & Society Conference Management (Nonprofit, Professional Bodies)
CodeTHAHACAAPrimaryNo
NAICS code3 codes
  • Business Associations813910
  • Convention and Trade Show Organizers56192
  • Convention and Trade Show Organizers561920
SIC code2 codes
  • Services-Membership Organizations8600
  • International Affairs9721
Product category
Health Policy Advocacy and Oncology Federation Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Member Society Fees and Participation
TypeSubscription Recurring
Description

As a not-for-profit federation, ECO generates revenue through membership fees from its 41 member societies, which include professional oncology societies and patient advocacy groups across Europe. Additional revenue comes from event participation fees for conferences and summits.

europeancancer.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ECCO is a not-for-profit federation that convenes 41 oncology member societies and patient advocacy groups across Europe to build consensus, publish policy guidance, and advocate for improved cancer care with EU and national policymakers. Its offerings include policy publications, benchmarking indices (European Cancer Screening Policy Index, HPV Prevention Policy Atlas), annual convening events (European Cancer Summit), thematic networks covering prevention, HPV, digital health, survivorship and workforce, and direct advocacy into EU institutions including Europe's Beating Cancer Plan.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Substantial influence on Europe's Beating Cancer Plan - submitted 12 key recommendations during 2020 consultation phase
+1 more record
Product overview1 text field

The European Cancer Organisation (ECO) is a not-for-profit federation that operates as a policy and advocacy organization rather than a traditional product company. Its offerings include policy publications and guides (such as the ECO Good Practice Guide on HPV Vaccination and the Closing the Gaps cervical cancer screening report), data visualization tools (European Cancer Pulse), policy frameworks (European Code of Cancer Practice, European Cancer Screening Policy Index), and conference/event programs (European Cancer Summit, Focused Topic Networks, Community 365, INTERACT-EUROPE 100). These resources work together to advocate for more effective, efficient, and equitable cancer care across Europe.

Product and service12 records
1ECO Good Practice Guide on HPV Vaccination
CategoryPolicy Publication / Guide
Description

A practical publication providing evidence-based principles and recommendations to help countries achieve high HPV vaccination coverage, targeting policymakers, programme managers, and patient organisations.

2Closing the Gaps: Cervical Cancer Screening Report
CategoryPolicy Report
Description

An analytical report providing an updated overview of how European countries are progressing towards cervical cancer elimination, identifying gaps and inequalities in screening implementation.

3HPV Prevention Policy Atlas Europe 2025
CategoryPolicy Tool / Atlas
Description

A benchmarking tool mapping HPV vaccination policies and coverage across Europe, identifying disparities and supporting accountability and evidence-based decision-making.

4European Cancer Summit
CategoryEvent / Conference
Description

Annual high-level gathering bringing together policymakers, healthcare professionals, patient advocates, and researchers to discuss and shape cancer policy priorities in Europe.

5Focused Topic Networks
CategoryNetwork / Community
Description

Nine specialised topic networks (including HPV Action, Prevention, Digital Health, Workforce, Survivorship, Health Systems, Research Policy, Inequalities, and Emergencies and Crises) that convene stakeholders to facilitate consensus and joint projects on specific cancer care issues.

6European Cancer Pulse
CategoryData Visualization Tool
Description

A unique data visualisation tool designed to track inequalities and monitor progress in cancer care across Europe, highlighting the factors that influence disparities in cancer care.

7European Code of Cancer Practice
CategoryPolicy Framework
Description

An initiative empowering European citizens and cancer patients with ten key overarching rights, signposting what cancer patients in Europe should expect from their healthcare system.

8European Cancer Screening Policy Index
CategoryPolicy Index / Benchmarking Tool
Description

A screening policy benchmarking tool tracking and comparing cancer screening policies across Europe to drive improvements and equitable access.

9INTERACT-EUROPE 100 Conference
CategoryEU Project / Conference
Description

A project-focused conference showcasing achievements of INTERACT-EUROPE 100 while charting the next phase of inter-specialty cancer training across Europe.

10Quality of Life and Cancer Policy Forum
CategoryEU Project / Forum
Description

High-level implementation-focused event featuring the EUonQoL project and Quality of Life - Patient-Centred Care Cluster of the EU Mission on Cancer, bringing together stakeholders to learn about latest EU-supported initiatives.

11Community 365
CategoryCommunity Program
Description

Year-round community initiative bringing together roundtable discussions and forums on various cancer care topics including patient-reported outcomes, cancer treatment and fertility, and AYA cancer care.

12Health Literacy and Digital Health Literacy Publication
CategoryPolicy Publication
Description

A publication addressing health literacy as a crucial element in the evolving healthcare landscape, particularly focusing on skills needed to assess and utilise health information on digital platforms.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-11
Description

ECO partners with ESGO for HPV prevention and cervical cancer elimination initiatives in Southeast Europe. Jointly organized regional conferences and developed policy tools including the ECO Good Practice Guide on HPV Vaccination and the HPV Prevention Policy Atlas Europe 2025.

2Romanian Football Federation (FRF)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-11
Description

ECO partnered with the Romanian Football Federation to host the 'One Region. One Goal: Eliminating HPV-related cancers in Southeast Europe' event in Bucharest. The partnership leverages football's broad social reach to promote HPV vaccination awareness and public health messaging.

europeancancer.org
3Founding Member Societies (EACR, EONS, ESMO, ESSO, ESTRO, SIOP Europe)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1981-01-01
Description

Six professional societies - European Association of Cancer Research (EACR), European Oncology Nursing Society (EONS), European Society of Medical Oncology (ESMO), European Society of Surgical Oncology (ESSO), European Society of Therapeutic Radiation and Oncology (ESTRO), and European Society for Paediatric Oncology (SIOP Europe) - legally founded the Federation of European Cancer Societies (FECS) in 1981, which later evolved into ECO.

europeancancer.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ECO maintains ongoing strategic engagement with EU institutions including the European Commission and European Parliament. ECO played a significant role in the design and implementation of Europe's Beating Cancer Plan, submitted 12 key recommendations during the 2020 consultation phase, and convenes the European Parliamentarians for Cancer Action group with 130+ members.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Brussels-based umbrella organization of European patient advocacy groups engaged in EU health policy. Directly comparable to ECCO's patient-facing convening function and EU-level policy advocacy model.

2Union for International Cancer Control (UICC)
TypeDirect peer
Description

Global cancer federation convening member organizations to influence cancer control policy worldwide. Closely analogous to ECCO in its federation-of-societies model and convening function, but with a global rather than European remit.

TypeDirect peer
Description

One of ECCO's six founding member societies and the leading European professional society for medical oncology. Directly comparable as a European oncology membership organization with its own policy advocacy, congress, and education programs.

TypeDirect peer
Description

Brussels-based federation of public health NGOs engaging EU institutions on health policy. Highly comparable to ECCO in governance structure, Brussels location, EU policy focus, and advocacy-driven mission.

5European Society for Radiotherapy & Oncology (ESTRO)
TypeDirect peer
Description

One of ECCO's six founding member societies and the European society for radiation oncology. Comparable as a European specialty oncology society with its own congress, education programs, and policy engagement.

TypeDirect peer
Description

One of ECCO's six founding member societies and the European professional society for paediatric oncology. Comparable in federation-style governance, EU policy engagement, and annual congress model.

TypeDirect peer
Description

European professional society for hematology with a similar federation-adjacent model, organizing congresses, publishing guidelines, and engaging EU policymakers on blood cancer policy — a natural comparable to ECCO for a different oncology sub-discipline.

TypeDirect peer
Description

European professional society for respiratory medicine with a Lausanne-based secretariat, annual congress, and EU policy engagement. Comparable to ECCO in professional society scale, international reach, and policy advocacy capacity for a different disease area.

TypeDirect peer
Description

Europe's leading professional society for hepatology with a Geneva-based secretariat, annual congress, and EU policy engagement. Closely comparable to ECCO in governance model, congress-driven GTM, and European-level policy advocacy in a disease-specific context.

TypeDirect peer
Description

Brussels-based federation of heart foundations and patient organizations across Europe. Most directly comparable disease-specific federation to ECCO in terms of Brussels location, EU-level advocacy, and federation-of-societies model — but focused on cardiovascular disease.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ECCO

Health Policy Advocacy and Oncology Federation Serviceseuropeancancer.org

The European Cancer Organisation is a Brussels-based not-for-profit federation of 41 oncology member societies and patient advocacy groups that convenes stakeholders, builds policy consensus, and influences EU cancer policy through the European Cancer Summit, Focused Topic Networks, and policy publications.

What ECCO does

The European Cancer Organisation (ECO, formerly ECCO and originally the Federation of European Cancer Societies) is a Brussels-based not-for-profit federation founded in 1981 and rebranded under its current name in 2007. It convenes 41 member societies and patient advocacy groups spanning oncology, nursing, surgical oncology, radiotherapy, paediatric oncology, and cancer research to build consensus and influence European cancer policy, most notably contributing to Europe's Beating Cancer Plan with 12 recommendations during the 2020 consultation. ECO operates nine Focused Topic Networks (Prevention/HPV/Quality of Life/Digital Health/Inequalities/Workforce/Research/Emergencies) and convenes the European Parliamentarians for Cancer Action group of more than 130 policymakers.

ECO's product surface is policy- and community-oriented rather than commercial. Offerings include the annual European Cancer Summit, Community 365 year-round roundtables, policy publications (ECO Good Practice Guide on HPV Vaccination, Closing the Gaps cervical cancer screening report, Essential Requirements for Quality Cancer Care series), data visualisation tools (European Cancer Pulse, European Cancer Screening Policy Index), and policy frameworks (European Code of Cancer Practice). It also delivers EU-funded projects including INTERACT-EUROPE 100 and EUonQoL.

ECO's business model is a subscription-style federation: recurring membership contributions from 41 member societies, event participation revenue, and project funding from EU programmes (including the EU Mission on Cancer). It does not sell commercial products or services. Pricing is not publicly disclosed. The customer base is fragmented across oncology professionals, patient advocates, EU institutions, and national policymakers, with EU institutional engagement concentrated in Brussels via its Rue de la Science 41 headquarters.

ECCO firmographics

Firmographics
Name
ECCO
Legal name
European Cancer Organisation
Website
https://europeancancer.org
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
11–50 employees
Short description
The European Cancer Organisation is a Brussels-based not-for-profit federation of 41 oncology member societies and patient advocacy groups that convenes stakeholders, builds policy consensus, and influences EU cancer policy through the European Cancer Summit, Focused Topic Networks, and policy publications.
Ownership category
akta.pro rank

ECCO industry classification

Industry
Product category
Health Policy Advocacy and Oncology Federation Services
NAICS
Business Associations (813910), Convention and Trade Show Organizers (56192), Convention and Trade Show Organizers (561920)
SIC
Services-Membership Organizations (8600), International Affairs (9721)
akta.pro primary industry
Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)
akta.pro secondary industries
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ), Association & Society Conference Management (Nonprofit, Professional Bodies) (THAHACAA)

Keywords

  • Cancer policy advocacy
  • Oncology federation
  • Health policy convening
  • Cancer care consensus
  • Multidisciplinary oncology

Where ECCO is headquartered

Location

Headquarters

HQ city
Brussels
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

ECCO business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

  1. Member Society Fees and Participation: As a not-for-profit federation, ECO generates revenue through membership fees from its 41 member societies, which include professional oncology societies and patient advocacy groups across Europe. Additional revenue comes from event participation fees for conferences and summits.

Go-to-market motion1 record

Marketing channels5 records

ECCO product offering

Product offering

Core offering

ECCO is a not-for-profit federation that convenes 41 oncology member societies and patient advocacy groups across Europe to build consensus, publish policy guidance, and advocate for improved cancer care with EU and national policymakers. Its offerings include policy publications, benchmarking indices (European Cancer Screening Policy Index, HPV Prevention Policy Atlas), annual convening events (European Cancer Summit), thematic networks covering prevention, HPV, digital health, survivorship and workforce, and direct advocacy into EU institutions including Europe's Beating Cancer Plan.

Product overview

The European Cancer Organisation (ECO) is a not-for-profit federation that operates as a policy and advocacy organization rather than a traditional product company. Its offerings include policy publications and guides (such as the ECO Good Practice Guide on HPV Vaccination and the Closing the Gaps cervical cancer screening report), data visualization tools (European Cancer Pulse), policy frameworks (European Code of Cancer Practice, European Cancer Screening Policy Index), and conference/event programs (European Cancer Summit, Focused Topic Networks, Community 365, INTERACT-EUROPE 100). These resources work together to advocate for more effective, efficient, and equitable cancer care across Europe.

Differentiator

Problem solved

Functional benefit

Products and services

  • ECO Good Practice Guide on HPV Vaccination A practical publication providing evidence-based principles and recommendations to help countries achieve high HPV vaccination coverage, targeting policymakers, programme managers, and patient organisations.
  • Closing the Gaps: Cervical Cancer Screening Report An analytical report providing an updated overview of how European countries are progressing towards cervical cancer elimination, identifying gaps and inequalities in screening implementation.
  • HPV Prevention Policy Atlas Europe 2025 A benchmarking tool mapping HPV vaccination policies and coverage across Europe, identifying disparities and supporting accountability and evidence-based decision-making.
  • European Cancer Summit Annual high-level gathering bringing together policymakers, healthcare professionals, patient advocates, and researchers to discuss and shape cancer policy priorities in Europe.
  • Focused Topic Networks Nine specialised topic networks (including HPV Action, Prevention, Digital Health, Workforce, Survivorship, Health Systems, Research Policy, Inequalities, and Emergencies and Crises) that convene stakeholders to facilitate consensus and joint projects on specific cancer care issues.
  • European Cancer Pulse A unique data visualisation tool designed to track inequalities and monitor progress in cancer care across Europe, highlighting the factors that influence disparities in cancer care.
  • European Code of Cancer Practice An initiative empowering European citizens and cancer patients with ten key overarching rights, signposting what cancer patients in Europe should expect from their healthcare system.
  • European Cancer Screening Policy Index A screening policy benchmarking tool tracking and comparing cancer screening policies across Europe to drive improvements and equitable access.
  • INTERACT-EUROPE 100 Conference A project-focused conference showcasing achievements of INTERACT-EUROPE 100 while charting the next phase of inter-specialty cancer training across Europe.
  • Quality of Life and Cancer Policy Forum High-level implementation-focused event featuring the EUonQoL project and Quality of Life - Patient-Centred Care Cluster of the EU Mission on Cancer, bringing together stakeholders to learn about latest EU-supported initiatives.
  • Community 365 Year-round community initiative bringing together roundtable discussions and forums on various cancer care topics including patient-reported outcomes, cancer treatment and fertility, and AYA cancer care.
  • Health Literacy and Digital Health Literacy Publication A publication addressing health literacy as a crucial element in the evolving healthcare landscape, particularly focusing on skills needed to assess and utilise health information on digital platforms.

Quantifiable outcome

  • Substantial influence on Europe's Beating Cancer Plan - submitted 12 key recommendations during 2020 consultation phase
  • +1 more outcomes

Companies that use ECCO

Customer profile

Segments3 records

Ideal customer profiles3 records

ECCO technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ECCO partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • European Society of Gynaecological Oncology (ESGO)coreStrategic or Co-development Partner · 11 May 2026ECO partners with ESGO for HPV prevention and cervical cancer elimination initiatives in Southeast Europe. Jointly organized regional conferences and developed policy tools including the ECO Good Practice Guide on HPV Vaccination and the HPV Prevention Policy Atlas Europe 2025.
  • Romanian Football Federation (FRF)minorStrategic or Co-development Partner · 11 May 2026ECO partnered with the Romanian Football Federation to host the 'One Region. One Goal: Eliminating HPV-related cancers in Southeast Europe' event in Bucharest. The partnership leverages football's broad social reach to promote HPV vaccination awareness and public health messaging.
  • Founding Member Societies (EACR, EONS, ESMO, ESSO, ESTRO, SIOP Europe)coreStrategic or Co-development Partner · 1 January 1981Six professional societies - European Association of Cancer Research (EACR), European Oncology Nursing Society (EONS), European Society of Medical Oncology (ESMO), European Society of Surgical Oncology (ESSO), European Society of Therapeutic Radiation and Oncology (ESTRO), and European Society for Paediatric Oncology (SIOP Europe) - legally founded the Federation of European Cancer Societies (FECS) in 1981, which later evolved into ECO.
  • European Institutions (European Commission, European Parliament)coreStrategic or Co-development PartnerECO maintains ongoing strategic engagement with EU institutions including the European Commission and European Parliament. ECO played a significant role in the design and implementation of Europe's Beating Cancer Plan, submitted 12 key recommendations during the 2020 consultation phase, and convenes the European Parliamentarians for Cancer Action group with 130+ members.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

ECCO competitors and assessment

Company assessment

Direct peers

  • European Patients' Forum (EPF): Brussels-based umbrella organization of European patient advocacy groups engaged in EU health policy. Directly comparable to ECCO's patient-facing convening function and EU-level policy advocacy model.
  • Union for International Cancer Control (UICC): Global cancer federation convening member organizations to influence cancer control policy worldwide. Closely analogous to ECCO in its federation-of-societies model and convening function, but with a global rather than European remit.
  • European Society for Medical Oncology (ESMO): One of ECCO's six founding member societies and the leading European professional society for medical oncology. Directly comparable as a European oncology membership organization with its own policy advocacy, congress, and education programs.
  • European Public Health Alliance (EPHA): Brussels-based federation of public health NGOs engaging EU institutions on health policy. Highly comparable to ECCO in governance structure, Brussels location, EU policy focus, and advocacy-driven mission.
  • European Society for Radiotherapy & Oncology (ESTRO): One of ECCO's six founding member societies and the European society for radiation oncology. Comparable as a European specialty oncology society with its own congress, education programs, and policy engagement.
  • European Society for Paediatric Oncology (SIOP Europe): One of ECCO's six founding member societies and the European professional society for paediatric oncology. Comparable in federation-style governance, EU policy engagement, and annual congress model.
  • European Hematology Association (EHA): European professional society for hematology with a similar federation-adjacent model, organizing congresses, publishing guidelines, and engaging EU policymakers on blood cancer policy — a natural comparable to ECCO for a different oncology sub-discipline.
  • European Respiratory Society (ERS): European professional society for respiratory medicine with a Lausanne-based secretariat, annual congress, and EU policy engagement. Comparable to ECCO in professional society scale, international reach, and policy advocacy capacity for a different disease area.
  • European Association for the Study of the Liver (EASL): Europe's leading professional society for hepatology with a Geneva-based secretariat, annual congress, and EU policy engagement. Closely comparable to ECCO in governance model, congress-driven GTM, and European-level policy advocacy in a disease-specific context.
  • European Heart Network (EHN): Brussels-based federation of heart foundations and patient organizations across Europe. Most directly comparable disease-specific federation to ECCO in terms of Brussels location, EU-level advocacy, and federation-of-societies model — but focused on cardiovascular disease.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ECCO social profiles

Digital presence

ECCO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ECCO leadership team

Management profile

Number of profiles

Profiles9 records

ECCO funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ECCO M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECCO

What does ECCO do?

ECCO is a not-for-profit federation that convenes 41 oncology member societies and patient advocacy groups across Europe to build consensus, publish policy guidance, and advocate for improved cancer care with EU and national policymakers. Its offerings include policy publications, benchmarking indices (European Cancer Screening Policy Index, HPV Prevention Policy Atlas), annual convening events (European Cancer Summit), thematic networks covering prevention, HPV, digital health, survivorship and workforce, and direct advocacy into EU institutions including Europe's Beating Cancer Plan.

Is ECCO a public or private company?

ECCO is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was ECCO founded?

ECCO was founded in 1981. It employs 11 to 50 people.

Where is ECCO based?

ECCO is headquartered in Brussels, Belgium, in the Europe region.

How does ECCO make money?

One revenue line is on record: member Society Fees and Participation.

Who are ECCO's main competitors?

Direct peers on record are European Patients' Forum (EPF), Union for International Cancer Control (UICC), European Society for Medical Oncology (ESMO), European Public Health Alliance (EPHA), European Society for Radiotherapy & Oncology (ESTRO), European Society for Paediatric Oncology (SIOP Europe), European Hematology Association (EHA), European Respiratory Society (ERS), European Association for the Study of the Liver (EASL) and European Heart Network (EHN).

Does ECCO have an API?

No public API is recorded for ECCO.

What industry is ECCO in?

ECCO's product category is Health Policy Advocacy and Oncology Federation Services. Its primary akta.pro industry code is HLAJAOAL, Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships, with a secondary code of BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation. Its NAICS code is 813910 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TradingViewAbivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026Abivax presented 22 abstracts at the European Crohn's and Colitis Organization's (ECCO) 21st Annual Congress on February 21, 2026, showcasing new preclinical and clinical data for obefazimod in inflammatory bowel disease. The data demonstrated the first evidence of anti-fibrotic activity in preclinical models (approximately 50-90% reduction in fibrosis markers), a favorable safety profile across 1,272 patients in Phase 3 ABTECT induction trials, and early symptomatic improvements observed from week 1 with remission at week 2. The company noted upcoming Phase 3 maintenance trial readout expected in Q2 2026 and Phase 2b ENHANCE-CD trial readout in Q4 2026.Investing.comAbivax reports 22 abstracts on obefazimod for IBD at ECCO 2026 By Investing.comAbivax SA announced that 22 scientific abstracts regarding its drug obefazimod for inflammatory bowel disease will be presented at the ECCO 2026 Congress in Stockholm. The presentations cover efficacy, safety, and preclinical data from Phase 3 trials, including specific insights into anti-fibrotic activity and patient-reported outcomes.EccoclimateWhat is the Global Conference on Environmental Taxation?The 26th Global Conference on Environmental Taxation (GCET26) took place in Porto Alegre, Brazil from September 24-26, 2025, bringing together academics, government representatives, and multilateral institution officials to discuss fiscal policy's role in the ecological and energy transition. An analysis presented by ECCO revealed that Italy's fiscal structure for energy carriers is inconsistent with its decarbonization objectives, primarily due to favorable treatment of fossil fuels over electricity. The conference also highlighted ongoing regulatory uncertainty around the EU's Carbon Border Adjustment Mechanism, with key implementing regulations still missing ahead of its final phase launch on January 1, 2026.PR NewswirePacienti s nemalobunkovým karcinómom pľúc s metastázami v mozgu: nové údaje o významných výzvach, na ktoré sa lekári necítia pripraveníA survey conducted by Ipsos MORI in collaboration with the European Cancer Organisation (E.C.O.) found that 40% of healthcare providers feel poorly equipped to treat patients with non-small cell lung cancer (NSCLC) who have brain metastases. The survey, which included 350 oncologists and respiratory specialists across the USA, UK, Germany, France, Spain, and Italy, also revealed that 39% of respondents reported difficulties with timely biomarker testing access and 52% cited lack of time for patient conversations. The survey was funded by Regeneron and Sanofi and its findings were presented at the E.C.O. Metastatic Cancer Community Round Table meeting on October 27, 2021.PR NewswirePatients atteints de cancer du poumon non à petites cellules avec métastases cérébrales : Nouvelles données sur les défis importants pour lesquels les médecins se sentent mal équipésAn Ipsos MORI survey commissioned by the European Cancer Organisation and funded by Regeneron and Sanofi found that 40% of 350 oncologists and pulmonologists across the United States, the United Kingdom, Germany, France, Spain, and Italy feel inadequately equipped to treat non-small cell lung cancer patients with brain metastases. The survey also revealed that 39% of respondents struggle to obtain timely biomarker testing, 75% find care coordination more difficult for these patients, and 52% lack sufficient time to discuss the disease with patients and caregivers. The findings were presented at the ECO Community 365 roundtable on metastatic cancer on 27 October 2021.PR NewswireПациенты с немелкоклеточным раком легких с метастазами мозга: новые данныеA survey conducted by Ipsos MORI for the European Cancer Organisation (E.C.O.) reveals that 40% of oncologists and respiratory specialists in the US and Europe feel ill-equipped to treat non-small cell lung cancer patients with brain metastases. The study, funded by Regeneron and Sanofi, highlights significant challenges in care coordination, timely access to biomarker testing, and providing adequate emotional support to patients and caregivers.PR NewswireCPCNP:Nuevos datos sobre los desafíos importantes para los que los médicos no se sienten equipadosA survey conducted by Ipsos MORI in collaboration with the European Cancer Organisation (ECO) found that 40% of 350 oncologists and respiratory specialists across the US, UK, Germany, France, Italy, and Spain feel inadequately equipped to treat patients with non-small cell lung cancer (NSCLC) with brain metastases. The survey, presented at ECO's Metastatic Cancer Community Roundtable on October 27, 2021, also revealed that care coordination is significantly more challenging for these patients, and half of providers report difficulties providing emotional support. The survey was funded by Regeneron and Sanofi to identify unmet patient needs.PR NewswirePacienti s nemalobuněčným karcinomem plic s mozkovými metastázami: Nové údaje o významných výzvách, na které lékaři nejsou připraveniA survey conducted by Ipsos MORI for the European Cancer Organisation (E.C.O.) found that 40% of healthcare providers across five European countries and the United States feel inadequately equipped to treat patients with non-small cell lung cancer (NSCLC) and brain metastases, with 39% also reporting challenges with timely biomarker testing. The survey of 350 oncologists and respiratory specialists identified significant care coordination difficulties, insufficient time for patient discussions (52%), and unmet patient information needs as key challenges in managing this patient population. The findings were presented at the E.C.O. Community 365 Roundtable Meeting on Metastatic Cancer on October 27, 2021.